A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Study of SHR-A1811 Combined With Pyrotinib and Bevacizumab in Advanced Breast Cancer With Brain Metastasis
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE1
A Study of TPST-1120 With Atezolizumab Plus Bevacizumab in Patients With Unresectable or Metastatic HCC Not Previously Treated With Systemic Therapy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
- Status
- RECRUITING
- Phase
- PHASE1
Intrathecal Injection Pemetrexed And Bevacizumab in Patients With Leptomeningeal Metastases in NSCLC
- Status
- RECRUITING
- Phase
- PHASE1
NEoadjuvant Olaparib Combination OvArian Cancer Targeted Study
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Clinical Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab or Atezolizumab Combined With Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
A Study Assessing Adverse Events and Disease Activity When Comparing Intravenously (IV) Infused ABBV-400 to Trifluridine and Tipiracil (LONSURF) Oral Tablets Plus IV Infused Bevacizumab in Adult Participants With c-Met Protein Above Cutoff Level Above Refractory Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Evaluate of PM8002 Combined With PM1009 in Patients With First-line HCC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin
- Status
- RECRUITING
- Phase
- PHASE1
Study of ZG005 Combined With Bevacizumab Versus Sintilimab Combined With Bevacizumab in Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
CSF CTC-Capture-Guided EGFR-TKI and Bevacizumab Combination Therapy in EGFR-Mutant Advanced NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
- Status
- RECRUITING
- Phase
- PHASE1
Study of ONO-4578 and XELOX/FOLFOX Plus Bevacizumab in Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2